Filter Results
:
(1,001)
Show Results For
-
All HBS Web
(1,001)
- People (4)
- News (249)
- Research (603)
- Events (7)
- Multimedia (24)
- Faculty Publications (389)
Show Results For
-
All HBS Web
(1,001)
- People (4)
- News (249)
- Research (603)
- Events (7)
- Multimedia (24)
- Faculty Publications (389)
- Portrait Project
Nicole Hanrahan
When I tell people I want to run an employment program for homeless drug addicts, many think I'm absolutely crazy. However, I want to devote my career to building just such a business. My pre-MBA experience of providing job training to...
View Details
- 06 Dec 2021
- News
Vision: Sound Science
of scientific inquiry in gene-based hearing loss and inner-ear drug delivery: “In some infants with profound hearing impairment, there’s a mutation in one of those genes that results in loss of a protein that inner-ear cells need to...
View Details
Keywords:
Deb Blagg
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
as 1994: That year was known among insiders as "The Year of the Placebo." What The Data Says The good news: One hundred thirty drugs can be traced to biotech, said Pisano. (For purposes of discussion during his presentation, he...
View Details
John J. Horan
Through heavy investments in research and development, Horan led Merck to become the leading U.S.-based manufacturer of prescription drugs in the world. Under Horan’s leadership, Merck doubled their spending on research – spending more...
View Details
Keywords:
Healthcare
- 18 Sep 2014
- News
Room to grow: global expansion in the middle ground
consulting firm Shaldor, documents the specific strategies various companies pursued. As examples, by focusing on a neglected market segment, Netafim became the world leader in drip irrigation technology, while Teva Pharmaceutical created a scalable, acquisition-based...
View Details
Robert F. Dee
During his CEO tenure, Dee achieved an 800% increase in revenues (over $3 billion) – moving SmithKline into the upper echelons of major pharmaceutical organizations. He introduced the anti-ulcer medication, Tagamet, which became the largest selling prescription View Details
Keywords:
Healthcare
- 01 Dec 2006
- News
Faculty Books
from its character as a science-based business. This poses three challenges: how to finance risky investments with long time horizons for R&D; keep pace with advances in drug knowledge; and integrate capabil-ities across the spectrum of...
View Details
- 01 Mar 2011
- News
Wyss Celebrated for Career, Conservation
orthopedic and trauma surgery. He continues to serve as chairman. In recognition of his career, the HBS Health Industry Alumni Association presented Wyss with the Beatrice D. Ellerin Alumni Achievement Award at its annual conference in November (see article "Fixing...
View Details
- Web
2.3.7 Physical Violence - MBA
2.3 Community Standards of Conduct 2.3.7 Physical Violence Welcome to HBS Being a Student at HBS 1. Academic Information & Policies 2. Integrity & Standards of Conduct 2.1 Academic Standards of Conduct 2.2 Recruiting Standards of Conduct 2.3 Community Standards of...
View Details
William B. Bell
coating resins, as well as melamine resins, which were used in making work surfaces impervious to scratches and stains. During the 1940s and 50s, Bell also expanded American Cyanamid's activities in drug research and production.
View Details
Keywords:
Chemicals & Industrial
- 01 Dec 2013
- News
To Market, to Market
chirality) of drug molecules with a high degree of accuracy for drug development and diagnostic applications. Chemical compounds excreted by predators that stimulate avoidance behavior in disease-carrying...
View Details
- 01 Sep 2017
- News
Ink: Miami’s Dark Neon Era, the Language of Success, and Getting Psyched Up
and two other amazing, true stories NEW Hotel Scarface by Roben Farzad “There’s so much unresolved about Miami’s cocaine coming-of-age. I found the address where the Cold War crashed into the war on drugs crashed into the cocaine wars...
View Details
Josiah K. Lilly
Lilly, a trained pharmacist and the founder of the family drug manufacturer, set up the first scientific division in the company and focused on standards of manufacturing and scientific development. Among other products, the company...
View Details
Keywords:
Healthcare
- 25 Apr 2014
- News
A revolution in healing
Stéphane Bancel (MBA 2000) is president and CEO of Moderna Therapeutics, which is producing a new drug application that could revolutionize the biotech world. It hinges on messenger RNA, or mRNA, the molecules responsible for transporting...
View Details
- Web
Kraft Accelerator
Jeff Elton speaks about how his company is building a world-class real-world data platform and tightly integrating it with AI-based tools and capabilities. We Need a Miracle: How Drug R&D Needs to Change to Cure Disease 12 SEP 2019 |...
View Details
Randall L. Tobias
The first outsider to run the company, Tobias is credited with orchestrating a major turnaround of Eli Lilly. Under his direction, Lilly introduced two successful drugs (Zyprexa for schizophrenia and Gemzar for cancer), solidified and...
View Details
Keywords:
Healthcare
- 01 Dec 2022
- News
Road to Recovery
illegal-drug addictions totaled an estimated $700 billion in direct and indirect costs, according to a 2015 report from the National Institute on Drug Abuse. DynamiCare developed an app that provides financial rewards via a debit card...
View Details
- Web
2.3.5 Research Misconduct - MBA
2.3 Community Standards of Conduct 2.3.5 Research Misconduct Welcome to HBS Being a Student at HBS 1. Academic Information & Policies 2. Integrity & Standards of Conduct 2.1 Academic Standards of Conduct 2.2 Recruiting Standards of Conduct 2.3 Community Standards of...
View Details
- Web
Business Track | New Venture Competition
Diagnostix is redefining precision agriculture through AI-powered, genetic insights. Team: Brandon Chi, MBA 2024; Joseph Swift; Amitesh Pratap; Leonie Luginbuehl. Play Video duration: 1:34 2024 New Venture Competition Runner-Up, Business Track: Sanso Sanso is helping...
View Details
- 29 Jun 2022
- Blog Post
Harvard Business School Announces the 2022-2023 Blavatnik Fellows
medicines. Hunter plans to use the Blavatnik Fellowship year to refine strategy and business development for the company’s novel drug delivery platform with his co-founders, Harvard Medical School Professor Dr. Wayne Lencer and Justin...
View Details